Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
13.69
+0.26 (1.94%)
At close: Mar 13, 2026, 4:00 PM EDT
13.72
+0.03 (0.22%)
After-hours: Mar 13, 2026, 7:00 PM EDT

Avanos Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-72.9-392.1-61.850.56.3
Depreciation & Amortization
38.945.546.147.738.3
Stock-Based Compensation
12.613.815.815.913.2
Other Adjustments
86.3437.972.71.18
Change in Receivables
30.9-6.639-24.7-10.8
Changes in Inventories
0.2394.7-30.915.7
Changes in Accounts Payable
0.6-0.9-14.435.4-11.9
Changes in Accrued Expenses
-12.9-11.4-27.7-7.133.4
Changes in Other Operating Activities
-9-24.5-423-4.9
Operating Cash Flow
74.7100.732.490.987.3
Operating Cash Flow Growth
-25.82%210.80%-64.36%4.12%-
Capital Expenditures
-31.6-17.8-17.8-19.3-21
Sale of Property, Plant & Equipment
4----
Payments for Business Acquisitions
-28--49.6-116.1-
Proceeds from Business Divestments
-2.189--
Other Investing Activities
-5-11.8---
Investing Cash Flow
-60.6-27.521.6-135.4-21
Short-Term Debt Issued
-205515020
Short-Term Debt Repaid
-25-45-115-170-70
Net Short-Term Debt Issued (Repaid)
-25-25-60-20-50
Long-Term Debt Issued
---250-
Long-Term Debt Repaid
-9.4-8.6-4.7-126.6-
Net Long-Term Debt Issued (Repaid)
-9.4-8.6-4.7123.4-
Issuance of Common Stock
0.71.11.31.76.2
Repurchase of Common Stock
-3.3-12.8-19.1-45.5-11.5
Net Common Stock Issued (Repurchased)
-2.6-11.7-17.8-43.8-5.3
Other Financing Activities
--3.8-11.7-2.9-
Financing Cash Flow
-37-49.1-94.256.7-55.3
Effect of Exchange Rate Changes on Cash and Cash Equivalents
5-4.10.2-3-4
Net Cash Flow
-17.920-409.27
Free Cash Flow
43.182.914.671.666.3
Free Cash Flow Growth
-48.01%467.81%-79.61%7.99%-
FCF Margin
6.15%12.05%2.17%10.47%11.29%
Free Cash Flow Per Share
0.931.800.311.511.36
Levered Free Cash Flow
24.7388.4-5481.7-6.7
Unlevered Free Cash Flow
-81.63-349.6-45.8457.3920.98
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q